Results 21 to 30 of about 131,791 (361)
Intravitreal Triamcinolone [PDF]
Ophthalmologica, 2010 <i>Background:</i> To provide an update on the intravitreal use of triamcinolone acetonide. <i>Methods:</i> Review of literature regarding triamcinolone-related research. <i>Results:</i> After the introduction of bevacizumab and ranibizumab into clinical practice, intravitreal triamcinolone has lost its leading ...
Yong, Tao, Jost B, Jonas
openaire +2 more sources
Journal of Ocular Pharmacology and Therapeutics, 2021 Inhibition of vascular endothelial growth factor is the mode of action for several approved therapies, including aflibercept, for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).
C. Gelfman +8 more
semanticscholar +1 more source
Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab
Journal of VitreoRetinal Diseases, 2020 Purpose: To analyze a case series of retinal vasculitis reported to the American Society of Retina Specialists (ASRS) following Food and Drug Administration approval of brolucizumab for treatment of neovascular age-related macular degeneration.
A. Witkin +12 more
semanticscholar +1 more source
Pharmaceutics, 2021 Background: Diabetic retinopathy (DR) is the leading cause of blindness in the working-age population. The purpose of this review is to gather the existing literature regarding the use of the approved anti-vascular endothelial growth (anti-VEGF) agents ...
I. Chatziralli, A. Loewenstein
semanticscholar +1 more source
Intravitreal Cotton Fiber Foreign Body after Intravitreal Injection
Case Reports in Ophthalmology, 2022 Iatrogenic intraocular foreign bodies (IOFBs) are rare findings to be associated with sterile intraocular procedures. They are usually observed in the anterior chamber, introduced during cataract surgery, while IOFBs in the posterior segment of the eye are very rare.
Fran Drnovšek, Xhevat Lumi
openaire +3 more sources
Comparison between “early” or “late” intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six months follow-up [PDF]
, 2017 AIM: The aim of this study was to compare early and late injections of intravitreal dexamethasone implant in patients affected by central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) with a six-months follow-up.
AUTOLITANO, MONICA +6 more
core +1 more source
Scientific Reports, 2020 The number of eye diseases treated with intravitreal injections is increasing. Obviously, an injection of fluid into the eye results in an increase of intraocular pressure (IOP), the main risk factor for glaucoma.
Victor A de Vries +2 more
semanticscholar +1 more source
Indian Journal of Ophthalmology, 2014 Background and Aims: This study documents a survey of final-year ophthalmology postgraduate students on the subject of their residency training. A similar survey conducted 7 years ago published in IJO had concluded that the residency program was not up ...
K Ajay, R Krishnaprasad
doaj +1 more source
An eighteen-month follow-up study on the effects of intravitreal dexamethasone implant in diabetic macular edema refractory to anti-VEGF therapy [PDF]
, 2016 AIM: To evaluate the long-term efficacy and safety of dexamethasone implants in subjects affected by diabetic macular edema (DME) resistant to anti-vascular endothelial growth factor (VEGF) therapy. METHODS: Thirty-two DME patients were enrolled.
Carnovale, Anna +7 more
core +1 more source
Graefe's Archive for Clinical and Experimental Ophthalmology, 2020 To quantify the shrinking in outpatient and intravitreal injections’ volumes in a tertiary referral retina unit secondary to virus causing coronavirus disease 2019 (COVID-19).
E. Borrelli +8 more
semanticscholar +1 more source